- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic ER+ Her2- Breast Cancer in Korea, Republic of
Total 1201 results
-
Samsung Medical CenterCompleted
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
Samsung Medical CenterKorean Cancer Study GroupCompletedAdvanced Breast CancerKorea, Republic of
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
MedPacto, Inc.AstraZenecaUnknownNon-Small Cell Lung Cancer MetastaticKorea, Republic of
-
National Nutrition and Food Technology InstituteUnknownBreast Cancer SurvivorsIran, Islamic Republic of
-
Seoul National University Bundang HospitalSeoul National University Hospital; SMG-SNU Boramae Medical Center; Yuhan Pharmaceutical... and other collaboratorsCompletedMetastatic or Recurrent Colorectal Cancer | Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan | Salvage ChemotherapyKorea, Republic of
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Hanmi Pharmaceutical Company LimitedUnknownBreast Cancer | Gastric Cancer | Unspecified Adult Solid Tumor, Protocol SpecificKorea, Republic of
-
Tehran University of Medical SciencesUnknownBreast Cancer Stage IVIran, Islamic Republic of
-
Samsung Medical CenterCompletedMetastatic Carcinoma | Recurrent Esophageal Squamous Cell CarcinomaKorea, Republic of
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Samsung Medical CenterRecruitingNon Small Cell Lung Cancer | Brain MetastasesKorea, Republic of
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Genentech, Inc.CompletedBreast CancerUnited States, Korea, Republic of
-
Yonsei UniversityActive, not recruitingBreast CancerKorea, Republic of
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Hoffmann-La RocheCompleted
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)Belgium, Spain, Korea, Republic of, United States, Taiwan, France, Canada
-
National Cancer Center, KoreaUnknownColorecal Neoplasms | SecondaryKorea, Republic of
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
AstraZenecaTerminatedGastric Cancer | Advanced Solid Malignancies | Solid Tumour | Child-Pugh A to B7 Advanced Hepatocellular Carcinoma | EGFR and/or ROS Mutant NSCLC | Lung Metastasis CarcinomaKorea, Republic of
-
Seoul National University HospitalCompletedLymph Node Metastases | Ovarian Cancer Stage IVKorea, Republic of
-
Isfahan University of Medical SciencesCompletedBreast Cancer SurvivorsIran, Islamic Republic of
-
Yonsei UniversityNot yet recruitingColorectal Cancer | Lung MetastasesKorea, Republic of
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
AstraZenecaRecruitingHER2-negativeDominican Republic, Panama, India, Brazil, Thailand, Indonesia, Malaysia, Mexico, Philippines, Singapore, Vietnam
-
National Nutrition and Food Technology InstituteUnknownBreast Cancer SurvivorsIran, Islamic Republic of
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Daiichi SankyoAstraZenecaRecruitingMetastatic Cancer | Advanced CancerSpain, Korea, Republic of, Belgium, Italy, France, United States, Australia, Japan, Taiwan, United Kingdom
-
Asan Medical CenterUnknownRectal Cancer | Liver MetastasesKorea, Republic of
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Sorrento Therapeutics, Inc.CompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
-
National Cancer Center, KoreaKorean Gynecologic Oncology GroupCompletedEndometrial CancerKorea, Republic of
-
Artiva Biotherapeutics, Inc.Not yet recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Pieris Pharmaceuticals, Inc.Active, not recruitingHER2-positive Gastric CancerUnited States, Korea, Republic of
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University Anam Hospital and other collaboratorsUnknownBreast Cancer | Gastric Cancer | Lung Cancer | Colon CancerKorea, Republic of
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
PfizerCompletedBreast CancerKorea, Republic of
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States